A multidisciplinary approach to T2D, obesity, and CVD: current evidence and a look to the future
Novo Nordisk A/S |
Tuesday
Chair: Ildiko Lingvay (USA) 19:00 – 19:10 Welcome and introductions: CV risk in people with T2D and/or obesity Ildiko Lingvay (USA) 19:10 – 19:28 The